170 related articles for article (PubMed ID: 26949719)
1. Microglial P2 Purinergic Receptor and Immunomodulatory Gene Transcripts Vary By Region, Sex, and Age in the Healthy Mouse CNS.
Crain JM; Watters JJ
Transcr Open Access; 2015 Dec; 3(2):. PubMed ID: 26949719
[TBL] [Abstract][Full Text] [Related]
2. Expression of P2 nucleotide receptors varies with age and sex in murine brain microglia.
Crain JM; Nikodemova M; Watters JJ
J Neuroinflammation; 2009 Aug; 6():24. PubMed ID: 19706184
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia Attenuates Purinergic P2X Receptor-Induced Inflammatory Gene Expression in Brainstem Microglia.
Smith SM; Mitchell GS; Friedle SA; Sibigtroth CM; Vinit S; Watters JJ
Hypoxia (Auckl); 2013 Aug; 2013(1):1-11. PubMed ID: 24377098
[TBL] [Abstract][Full Text] [Related]
4. Microglia express distinct M1 and M2 phenotypic markers in the postnatal and adult central nervous system in male and female mice.
Crain JM; Nikodemova M; Watters JJ
J Neurosci Res; 2013 Sep; 91(9):1143-51. PubMed ID: 23686747
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the purinergic P2X7 receptor attenuates lipopolysaccharide-mediated microglial activation and neuronal damage in inflamed brain.
Choi HB; Ryu JK; Kim SU; McLarnon JG
J Neurosci; 2007 May; 27(18):4957-68. PubMed ID: 17475804
[TBL] [Abstract][Full Text] [Related]
6. Neuronal injury in chronic CNS inflammation.
Zindler E; Zipp F
Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
[TBL] [Abstract][Full Text] [Related]
7. Distinct activation profiles in microglia of different ages: a systematic study in isolated embryonic to aged microglial cultures.
Lai AY; Dibal CD; Armitage GA; Winship IR; Todd KG
Neuroscience; 2013 Dec; 254():185-95. PubMed ID: 24042036
[TBL] [Abstract][Full Text] [Related]
8. P2X7 nucleotide receptor activation enhances IFN gamma-induced type II nitric oxide synthase activity in BV-2 microglial cells.
Gendron FP; Chalimoniuk M; Strosznajder J; Shen S; González FA; Weisman GA; Sun GY
J Neurochem; 2003 Oct; 87(2):344-52. PubMed ID: 14511112
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiological roles of extracellular nucleotides in glial cells: differential expression of purinergic receptors in resting and activated microglia.
Bianco F; Fumagalli M; Pravettoni E; D'Ambrosi N; Volonte C; Matteoli M; Abbracchio MP; Verderio C
Brain Res Brain Res Rev; 2005 Apr; 48(2):144-56. PubMed ID: 15850653
[TBL] [Abstract][Full Text] [Related]
10. Ion channels on microglia: therapeutic targets for neuroprotection.
Skaper SD
CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):44-56. PubMed ID: 21143139
[TBL] [Abstract][Full Text] [Related]
11. Loss of NF-κB p50 function synergistically augments microglial priming in the middle-aged brain.
Taetzsch T; Benusa S; Levesque S; Mumaw CL; Block ML
J Neuroinflammation; 2019 Mar; 16(1):60. PubMed ID: 30871598
[TBL] [Abstract][Full Text] [Related]
12. Estrogen modulates microglial inflammatory mediator production via interactions with estrogen receptor beta.
Baker AE; Brautigam VM; Watters JJ
Endocrinology; 2004 Nov; 145(11):5021-32. PubMed ID: 15256495
[TBL] [Abstract][Full Text] [Related]
13. Sex- and Region-Specific Differences in the Transcriptomes of Rat Microglia from the Brainstem and Cervical Spinal Cord.
Ewald AC; Kiernan EA; Roopra AS; Radcliff AB; Timko RR; Baker TL; Watters JJ
J Pharmacol Exp Ther; 2020 Oct; 375(1):210-222. PubMed ID: 32661056
[TBL] [Abstract][Full Text] [Related]
14. Estrogen and P2 Purinergic Receptor Systems in Microglia: Therapeutic Targets for Neuroprotection.
Crain JM; Watters JJ
Open Drug Discov J; 2010 Jan; 2():148-167. PubMed ID: 21961028
[TBL] [Abstract][Full Text] [Related]
15. Necrotic neurons enhance microglial neurotoxicity through induction of glutaminase by a MyD88-dependent pathway.
Pais TF; Figueiredo C; Peixoto R; Braz MH; Chatterjee S
J Neuroinflammation; 2008 Oct; 5():43. PubMed ID: 18844999
[TBL] [Abstract][Full Text] [Related]
16. Distinct P2Y Receptors Mediate Extension and Retraction of Microglial Processes in Epileptic and Peritumoral Human Tissue.
Milior G; Morin-Brureau M; Chali F; Le Duigou C; Savary E; Huberfeld G; Rouach N; Pallud J; Capelle L; Navarro V; Mathon B; Clemenceau S; Miles R
J Neurosci; 2020 Feb; 40(7):1373-1388. PubMed ID: 31896671
[TBL] [Abstract][Full Text] [Related]
17. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L
J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429
[TBL] [Abstract][Full Text] [Related]
18. Microglial phagocytosis attenuated by short-term exposure to exogenous ATP through P2X receptor action.
Fang KM; Yang CS; Sun SH; Tzeng SF
J Neurochem; 2009 Dec; 111(5):1225-37. PubMed ID: 19860838
[TBL] [Abstract][Full Text] [Related]
19. CHF5074 (CSP-1103) induces microglia alternative activation in plaque-free Tg2576 mice and primary glial cultures exposed to beta-amyloid.
Porrini V; Lanzillotta A; Branca C; Benarese M; Parrella E; Lorenzini L; Calzà L; Flaibani R; Spano PF; Imbimbo BP; Pizzi M
Neuroscience; 2015 Aug; 302():112-20. PubMed ID: 25450955
[TBL] [Abstract][Full Text] [Related]
20. ATP selectively suppresses the synthesis of the inflammatory protein microglial response factor (MRF)-1 through Ca(2+) influx via P2X(7) receptors in cultured microglia.
Kaya N; Tanaka S; Koike T
Brain Res; 2002 Oct; 952(1):86-97. PubMed ID: 12363408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
